Patents by Inventor Christopher Sledem

Christopher Sledem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
    Publication number: 20060089347
    Abstract: The present invention discloses novel substituted azepine compounds of Formula (I) or pharmaceutically acceptable salts thereof which have selective histamine-H3 receptor antagonist activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such azepines as well as methods of using them to treat obesity and other histamine H3 receptor-related diseases.
    Type: Application
    Filed: August 15, 2003
    Publication date: April 27, 2006
    Applicant: Eli Lilly and Company
    Inventors: Robert Gadski, Phillip Hipskind, Cynthia Jesudason, Richard Pickard, Lisa Beavers, Christopher Sledem, Alay Singh